Pierre Legault Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Pierre Legault.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Pierre Legault. Pierre Legault is Director in NPS PHARMACEUTICALS INC ($NPSP) and Director in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Tobira Therapeutics, Inc. ($TBRA) and Chief Executive Officer in NephroGenex, Inc. ($NRX) and in Syndax Pharmaceuticals Inc ($SNDX) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in Urovant Sciences Ltd. ($UROV) and Director in BICYCLE THERAPEUTICS plc ($BCYC).
Latest Insider Trading Transactions of Pierre Legault
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARMO, BCYC, CYCC, NRX, NPSP, SNDX, TBRA, UROV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 09 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.74 | 24,838 | 217,084 | 173,312 | |
Apr 09 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 32.13 | 239 | 7,679 | 0 | 239 to 0 (-100.00 %) |
Apr 09 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 31.40 | 12,099 | 379,909 | 239 | 12.3 K to 239 (-98.06 %) |
Apr 09 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 32.00 | 12,500 | 400,000 | 12,338 | 24.8 K to 12.3 K (-50.33 %) |
Apr 09 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.74 | 24,838 | 217,084 | 24,838 | 0 to 24.8 K |
Apr 07 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.83 | 162 | 1,430 | 198,150 | |
Apr 07 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 31.07 | 162 | 5,033 | 0 | 162 to 0 (-100.00 %) |
Apr 07 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.83 | 162 | 1,430 | 162 | 0 to 162 |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.78 | 10,000 | 87,800 | 198,312 | |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 30.00 | 10,000 | 300,000 | 0 | 10 K to 0 (-100.00 %) |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.78 | 10,000 | 87,800 | 198,312 | |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.78 | 10,000 | 87,800 | 10,000 | 0 to 10 K |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 30.00 | 10,000 | 300,000 | 0 | 10 K to 0 (-100.00 %) |
Apr 02 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.78 | 10,000 | 87,800 | 10,000 | 0 to 10 K |
Mar 19 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.85 | 7,784 | 68,888 | 208,312 | |
Mar 19 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 29.00 | 7,784 | 225,736 | 0 | 7.8 K to 0 (-100.00 %) |
Mar 19 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.85 | 7,784 | 68,888 | 7,784 | 0 to 7.8 K |
Mar 16 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | M | 8.86 | 2,216 | 19,634 | 216,096 | |
Mar 16 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Sell | S | 29.00 | 2,216 | 64,264 | 0 | 2.2 K to 0 (-100.00 %) |
Mar 16 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Buy | M | 8.86 | 2,216 | 19,634 | 2,216 | 0 to 2.2 K |
Feb 05 2021 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Grant | A | 0.00 | 16,000 | 0 | 16,000 | 0 to 16 K | |
Jan 05 2021 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | A | 17.95 | 38,000 | 682,100 | 38,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 9.38 | 15,000 | 140,700 | 15,000 | |
Jul 23 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Grant | A | 0.00 | 9,000 | 0 | 21,480 | 12.5 K to 21.5 K (+72.12 %) |
Jan 14 2020 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |
Jan 06 2020 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | A | 9.82 | 32,000 | 314,240 | 32,000 | |
Jul 11 2019 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.78 | 25,000 | 219,500 | 25,000 | |
Jun 12 2019 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 7.88 | 24,000 | 189,120 | 24,000 | ||
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | A | 14.00 | 116,827 | 1,635,578 | 116,827 | |
May 30 2019 | BCYC | BICYCLE THERAPEUTI ... | Legault Pierre | Director | Option Exercise | A | 14.00 | 116,827 | 1,635,578 | 116,827 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Nov 26 2018 | UROV | Urovant Sciences L ... | Legault Pierre | Director | Option Exercise | A | 8.01 | 36,650 | 293,567 | 36,650 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | D | 6.73 | 55,765 | 375,538 | 0 | |
Jun 22 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | D | 39.97 | 18,000 | 719,460 | 0 | |
May 25 2018 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 8.93 | 14,000 | 125,020 | 14,000 | ||
Mar 28 2018 | ARMO | ARMO BioSciences, ... | Legault Pierre | Director | Option Exercise | A | 39.97 | 18,000 | 719,460 | 18,000 | |
Feb 12 2018 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 9.63 | 10,000 | 96,300 | 10,000 | ||
May 19 2017 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 13.58 | 5,000 | 67,900 | 5,000 | ||
May 19 2017 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 13.58 | 10,000 | 135,800 | 10,000 | ||
Jan 05 2017 | SNDX | Syndax Pharmaceuti ... | Legault Pierre | Option Exercise | A | 7.08 | 20,000 | 141,600 | 20,000 | ||
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 8.19 | 17,695 | 144,922 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 7.91 | 17,778 | 140,624 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 16.52 | 15,500 | 256,060 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 42.93 | 535 | 22,968 | 0 | |
Nov 03 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | D | 43.83 | 6,111 | 267,845 | 0 | |
Jan 14 2016 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 7.91 | 17,778 | 140,624 | 17,778 | |
Nov 12 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Grant | A | 0.00 | 646,930 | 0 | 659,430 | 12.5 K to 659.4 K (+5,175.44 %) |
Jul 13 2015 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 16.52 | 15,500 | 256,060 | 15,500 | |
May 04 2015 | NRX | NephroGenex, Inc. | Legault Pierre | Chief Executive Off ... | Option Exercise | A | 7.31 | 50,000 | 365,500 | 50,000 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Legault Pierre | Director | Option Exercise | D | 0.00 | 3,816 | 0 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Legault Pierre | Director | Option Exercise | D | 27.29 | 20,257 | 552,814 | 0 | |
Feb 21 2008 | CYCC | Cyclacel Pharmaceu ... | Legault Pierre | Director | Option Exercise | A | 4.31 | 35,000 | 150,850 | 35,000 | |
Mar 13 2007 | CYCC | Cyclacel Pharmaceu ... | Legault Pierre | Director | Option Exercise | A | 7.80 | 35,000 | 273,000 | 35,000 |
Page: 1